Robert J. Gould
2023 - Fulcrum Therapeutics
In 2023, Robert J. Gould earned a total compensation of $424.5K as Former Interim President and Chief Executive Officer at Fulcrum Therapeutics, a 259% increase compared to previous year.
Compensation breakdown
| Option Awards | $76,404 |
|---|---|
| Salary | $300,000 |
| Other | $48,097 |
| Total | $424,501 |
Gould received $300K in salary, accounting for 71% of the total pay in 2023.
Gould also received $76.4K in option awards and $48.1K in other compensation.
Rankings
In 2023, Robert J. Gould's compensation ranked 2,217th out of 2,978 executives tracked by ExecPay. In other words, Gould earned more than 25.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,217 out of 2,978 | 26th |
Division Manufacturing | 1,257 out of 1,637 | 23rd |
Major group Chemicals And Allied Products | 749 out of 906 | 17th |
Industry group Drugs | 731 out of 869 | 16th |
Industry Pharmaceutical Preparations | 526 out of 627 | 16th |
Source: SEC filing on April 19, 2024.
Gould's colleagues
We found five more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Bryan Stuart
Fulcrum Therapeutics